Personalis (United States)

company in Menlo Park, United States

PSNL Nasdaq SEC CIK 1527753 LEI 549300EZ2NYFK7H0US48
Follow Personalis (United States) Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $25.6M +76.6% vs same quarter last year
Net income −$33.8M −56.1% vs same quarter last year
EPS, diluted −$0.32 −33.3% vs same quarter last year
Operating cash flow −$27.1M −24.2% vs same quarter last year
Revenue by quarter
$16.8M
$20.6M
$17.2M
$14.5M
$17.3M
$15.5M
$22.4M
$25.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50M$100MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$69.6M−$81.3M
FY24$84.6M−$81.3M
FY23$73.5M−$108.3M
FY22$65M−$113.3M
FY21$85.5M−$65.2M
FY20$78.6M−$41.3M
FY19$65.2M−$25.1M
FY18$37.8M−$19.9M
FY17$9.4M−$23.6M
FY16--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300%−200%−100%0%100%FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2522.7%−126.4%−116.7%
FY2431.7%−80.7%−96.1%
FY2324.8%−149.6%−147.4%
FY2220.5%−177.6%−174.2%
FY2137%−76.4%−76.3%
FY2025.6%−53.6%−52.5%
FY1933.9%−34.4%−38.5%
FY1831.3%−36.5%−52.6%
FY17−24.9%−236%−251.2%
FY16---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$79.5M
FY24−$46.8M
FY23−$67.2M
FY22−$120.1M
FY21−$81.9M
FY20−$45.9M
FY19−$26.5M
FY18−$2.3M
FY17−$4.9M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Personalis (United States)
  • Healthcare median
−300%−200%−100%0%FY17FY19FY21FY23FY25
Show the numbers
YearPersonalis (United States)Healthcare median
FY25−116.7%−30.6%
FY24−96.1%−47%
FY23−147.4%−58%
FY22−174.2%−80.4%
FY21−76.3%−71.8%
FY20−52.5%−62.2%
FY19−38.5%−46.2%
FY18−52.6%−49.6%
FY17−251.2%−45.9%
FY16-−36%